Stock listing
OTC:TLOG Tetralogic Pharmaceuticals Corp Stock
Follow Tetralogic Pharmaceuticals Corp into a list and get an email when it puts out news.
Share price · OTC:TLOG
$0.0001 USD 0.0000 (0.0%)
Close on Nov 19, 2026 · Data provided by Twelve Data
- Day range
- $0.0001 – $0.0001 USDNov 19, 2026
- Market cap
- —Left out: price × shares is far from the company's reported size
- 52-week range
- $0.0000 – $0.0002 USDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- $0 USDMedian day 0 shares · 65 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026

Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · OTC:TLOG · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | +0.0001 | +150.0% | $0.0001 | $0.0001 | $0.0001 | 16,400 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 | |
| $0.0000 | 0.0000 | 0.0% | $0.0000 | $0.0000 | $0.0000 | 0 |
- Ticker
- OTC:TLOG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Tetralogic Pharmaceuticals Corp on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- Decks
- 3 decks · latest Sep 28, 2015
Valuation
price Nov 19, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 0.00
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2015) | Investor deck | 28 slides | Sep 28, 2015 |
| Investor Presentation (April 2015) | Investor deck | 27 slides | Apr 30, 2015 |
| Investor Presentation (April 2014) | Investor deck | 27 slides | Apr 8, 2014 |
Cap table
Built by 6ix from Tetralogic Pharmaceuticals Corp’s releases
- Common shares
- 24,465,083
- Fully diluted
- 24,465,083
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 24,465,083 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 24,465,083 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| J. Kevin Buchi Other companies: Benitec Biopharma Inc. (Director · Since at least Apr 15, 2020); Amneal Pharmaceuticals, Inc. (Director · Since at least May 4, 2018); Ampio Pharmaceuticals, Inc. (Director · Oct 13, 2021 – Jun 9, 2023 · Past); Alaunos Therapeutics, Inc. (Director · Sep 21, 2020 – Mar 4, 2021 · Past); BioSpecifics Technologies Corp (Chief Executive Officer, Director · Oct 8, 2019 – Oct 23, 2019 · Past); Dicerna Pharmaceuticals Inc (Director · Aug 13, 2018 – Dec 28, 2021 · Past); Impax Laboratories Inc (Director · Nov 23, 2016 – May 4, 2018 · Past); EPIRUS Biopharmaceuticals Inc (Director · Jul 15, 2014 – Jun 5, 2015 · Past); Stemline Therapeutics Inc (Director · Jan 28, 2013 – Jun 23, 2015 · Past); Alexza Pharmaceuticals Inc (Director · Jan 2, 2013 – Jun 21, 2016 · Past); Encysive Pharmaceuticals Inc (Director · May 12, 2006 – Apr 1, 2008 · Past); Cephalon Inc (Chief Executive Officer, Director · Feb 17, 2006 – Oct 14, 2011 · Past) | President & CEO, Director · Dec 11, 2013 – Mar 26, 2015 · Past |
| Lesley Russell Other companies: Enanta Pharmaceuticals, Inc. (Director · Since at least Nov 18, 2016); Scopus BioPharma, Inc. (Director · Dec 16, 2020 – Dec 16, 2020 · Past); Innocoll AG (Chief Medical Officer · Jan 1, 2017 – Jul 24, 2017 · Past); Endocyte Inc (Director · Jan 4, 2013 – Dec 21, 2018 · Past); AMAG Pharmaceuticals Inc (Director · Dec 16, 2009 – Jun 7, 2018 · Past); Cephalon Inc (Exec VP, Chief Medical Off · Sep 1, 2006 – Oct 14, 2011 · Past) | Chief Operating Officer · Dec 11, 2013 – Jan 28, 2015 · Past |
| Andrew L Pecora Other companies: Celularity Inc. (President · Sep 15, 2021 – Sep 15, 2021 · Past); Cancer Genetics Inc (Director · Apr 4, 2013 – Nov 18, 2013 · Past); Lisata Therapeutics, Inc. (Director · Jan 19, 2011 – Jun 22, 2016 · Past) | Director · Dec 11, 2013 – Jul 10, 2015 · Past |
| Brenda D Gavin Other companies: Ocera Therapeutics Inc (Director · Apr 1, 2011 – Apr 19, 2011 · Past); Tengion Inc (Director · Apr 9, 2010 – Apr 9, 2010 · Past) | Director · Dec 11, 2013 – Dec 31, 2013 · Past |
| James N Woody Other companies: Forum Markets, Incorporated (Chief Executive Officer, Director · Nov 6, 2020 – Dec 15, 2023 · Past); OncoMed Pharmaceuticals Inc (Director · Jul 17, 2013 – Jul 23, 2013 · Past) | Director · Dec 11, 2013 – Jan 28, 2015 · Past |
| Pete Meyers Other companies: Immutep Ltd (Director · Since at least Mar 18, 2026); Eagle Pharmaceuticals, Inc. (Chief Financial Officer · May 15, 2017 – Jan 23, 2020 · Past) | CFO & Treasurer · Dec 11, 2013 – Mar 27, 2015 · Past |
| John M. Gill Other companies: Altimmune, Inc. (Director · Since at least Jun 11, 2013) | Director · Dec 11, 2013 – Dec 31, 2013 · Past |
| Patrick Hutchison Other companies: BioSpecifics Technologies Corp (Chief Financial Officer · Jan 6, 2020 – Dec 2, 2020 · Past) | CFO & Treasurer · Apr 30, 2016 – Apr 30, 2016 · Past |
| Paul J Schmitt Other companies: Encorium Group Inc (Director · Feb 15, 2007 – Mar 30, 2007 · Past) | Director · Dec 11, 2013 – Jul 2, 2015 · Past |
| Richard L Sherman Other companies: Immunomedics Inc (Director · Aug 15, 2013 – Dec 1, 2015 · Past) | See Remarks · Dec 11, 2013 – Jan 28, 2015 · Past |
All 11 people
| Person | Seat |
|---|---|
| Douglas MD Reed | Director · Dec 11, 2013 – Jan 28, 2015 · Past |
Log in to ask 6ix AI your own questions about Tetralogic Pharmaceuticals Corp.